US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Sterile Water for Injection USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0013-06 D-1031-2022
Class II · Moderate risk Terminated

Spinal Tray

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office D-1030-2022
Class II · Moderate risk Terminated

Ciprofloxacin Ophthalmic Solution 0.3%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-0656-10 D-1029-2022
Class II · Moderate risk Terminated

Betamethasone Dipropionate Cream USP

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0055-46 D-1028-2022
Class II · Moderate risk Terminated

Aprepitant Capsule

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2321-06 D-1027-2022
Class II · Moderate risk Terminated

Amoxicillin Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2613-01 D-1025-2022
Class II · Moderate risk Terminated

Adrenalin

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 42023-168-01 D-1022-2022
Class II · Moderate risk Terminated

Albuterol Sulfate Inhalation Solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-0301-01 D-1018-2022
Class II · Moderate risk Terminated

GlucaGen

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0260-10 D-1017-2022
Class II · Moderate risk Terminated

Firmagon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8403-01 D-1016-2022
Class II · Moderate risk Terminated

Firmagon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55566-8303-01 D-1015-2022
Class II · Moderate risk Terminated

Epinephrine Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-101-02 D-1014-2022
Class II · Moderate risk Terminated

Epinephrine Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-102-02 D-1013-2022
Class II · Moderate risk Terminated

EPI-Pen Jr

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49502-501-02 D-1012-2022
Class II · Moderate risk Terminated

Dihydroergotamine Mesylate

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0574-0850-10 D-1011-2022
Class II · Moderate risk Terminated

Epidural Tray

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office D-1010-2022
Class II · Moderate risk Terminated

Ampicillin for Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-113-10 D-1009-2022
Class II · Moderate risk Terminated

Betadine 5%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0411-30 D-1008-2022
Class II · Moderate risk Terminated

Sumatriptan Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-0173-01 D-1007-2022